Big movements in Zomedica stock price on Monday moving 10.42% between high and low

The Zomedica stock price gained 6.93% on the last trading day (Monday, 9th Jan 2023), rising from $0.234 to $0.250. It has now gained 5 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 10.42% from a day low at $0.240 to a day high of $0.265. The price has been going up and down for this period, and there has been a 51.55% gain for the last 2 weeks. Volume fell on the last day by -86 million shares and in total, 22 million shares were bought and sold for approximately $5.51 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

Dawson James is very positive about ZOM and gave it a "" rating on Jan 06, 2023. The price target was set to 6.Over the last 90 days, this security got 1 buy, 0 sell, and 0 hold ratings.

The stockhas broken the very wide and falling short-term trend up. Firstly a slower falling rate is indicated, but this may very well be an early signal of a trend shift. On the reaction, there will be support on the roof of the current trend broken, which is $0.215, a level that may pose a second chance to hit a runner. According to fan-theory $0.277 will be the next possible trend-top level and thereby pose a resistance level that may not be broken at the first attempt.

Mostly positive signals in the chart today. The Zomedica stock holds buy signals from both short and long-term moving averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $0.190 and $0.191. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Wednesday, December 28, 2022, and so far it has risen 57.96%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely.

On the downside, the stock finds support just below today's level from accumulated volume at $0.234 and $0.230.There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Zomedica finds support just below today's level at $0.234. If this is broken, then the next support from accumulated volume will be at $0.230 and $0.200.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.0250 between high and low, or 10.42%. For the last week, the stock has had daily average volatility of 15.87%.

Several short-term signals are positive and the break-up from the falling trend indicates a possible shift for a trend. We believe that the prices around the breaking point will indicate particularly good levels, but we also believe that the current level will hold a possible good buy level for the short-term period.